Skip to main content

Table 3 DA, DV, and BFV of AVF in six-time points (\(\overline{x}\) ± SD)

From: A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae

  

MLPN group (n = 37)

Control group (n = 37)

t

P

T0

DA, mm

2.59 ± 0.99

2.51 ± 0.76

0.425

0.672

DV, mm

2.69 ± 0.79

2.76 ± 0.86

0.387

0.700

T1

DA, mm

3.60 ± 0.96***

3.41 ± 0.76***

0.912

0.375

DV, mm

4.12 ± 0.98***

3.59 ± 0.89***

2.463

0.016

BFV, ml/min

771.9 ± 374.42

571.51 ± 305.38

2.503

0.015

T2

DA, mm

3.97 ± 0.96***

3.91 ± 0.88***

0.266

0.791

DV, mm

4.44 ± 0.82***

3.99 ± 1.22***

1.831

0.071

BFV, ml/min

935.49 ± 444.01

752.97 ± 395.38#

1.867

0.066

T3

DA, mm

4.26 ± 1.03***

4.08 ± 0.94***

0.776

0.440

DV, mm

4.86 ± 1.00***

4.37 ± 1.28***

1.849

0.069

BFV, ml/min

996.30 ± 456.86#

811.72 ± 424.29##

1.801

0.076

T4

DA, mm

4.65 ± 1.03***

4.23 ± 1.00***

1.780

0.079

DV, mm

5.03 ± 1.07***

4.70 ± 1.47***

1.138

0.259

BFV, ml/min

1183.87 ± 739.26##

864 ± 467.01##

2.232

0.029

T5

DA, mm

4.72 ± 1.26***

5.07 ± 1.14***

0.370

0.712

DV, mm

5.13 ± 1.08***

4.90 ± 1.51***

0.706

0.483

BFV, ml/min

1078.10 ± 590.04##

957.75 ± 648.43##

0.780

0.438

  1. ***Significant different compared to T0 (P < 0.001)
  2. # Significant different compared to T1 (P < 0.05), ##Significant different compared to T1 (P < 0.01)
  3. AVF: arteriovenous fistula; MLPN: moxibustion at Laogong interval with Panax notoginseng; DA: diameter of anastomosis; DV: diameter of draining veins; BFV: blood flow of draining veins